HTTP 200 verified twice
Finding your next stop…
Loading the latest directory information.
Loading the latest directory information.
Niramai Health Analytix provides AI-driven breast cancer screening using its patented Thermalytix technology, which fuses artificial intelligence with breast thermal scans. The non-invasive, radiation-free solution is available in 200+ hospitals across 30 cities and 150+ locations in multiple countries.
Start here for the decision-making essentials: what Niramai does, who it is for, how it is accessed, and the first-party sources behind this profile.
See official pricing
Read-only public captures of Niramai’s homepage. Screenshots are dated, never live embeds, and open full-screen.
Short answers to the questions buyers and builders commonly ask about Niramai. Each answer cites the shared ledger below, where every source is listed once.
AI-driven, non-invasive, radiation-free breast cancer screening
AI-driven breast cancer screening with accurate, non-invasive, radiation-free early detection
Women of all ages; recommended annually for women above 25 years
works for women of all ages
Early stage breast cancer detection via Thermalytix AI medical device
Thermalytix is a Novel Artificial Intelligence based medical device for detecting early stage breast cancer
Available in 200+ hospitals across 30 cities and 150+ locations
available in 200+ hospitals across 30 cities
Compliance with ISO 27001, GDPR, HIPAA, and DPDP standards
Ensure compliance with industry standards such as: ISO 27001, GDPR, HIPAA, DPDP etc.
Series A funded by Pi Ventures, Axilor, Ankur Capital, Binny Bansal, Dream Incubator (Japa
Series A funded company from popular Indian investors such as Pi Ventures, Axilor, Ankur Capital, Binny Bansal and international investors such as Dream Incubator (Japan) , BeeNext (Singapore) and 500 Startups(US)
This profile connects the jobs Niramai is described as handling with its delivery model, access options and the subjects used to match it to related products in this directory.
Each fact points to a recorded source, making it easy to distinguish verified product information from claims that need checking.
HTTP 200 verified twice
early breast cancer detection | NIRAMAI Health Analytix
Company name: NIRAMAI Health Analytix Private Limited · Founded July 2016 · Headquartered in Bangalore, India (J P Nagar 7th Phase)
NIRAMAI Health Analytix Private Limited
July 2016
Bangalore, India (J P Nagar 7th Phase)
AI-driven, non-invasive, radiation-free breast cancer screening
Early stage breast cancer detection via Thermalytix AI medical device
Women of all ages; recommended annually for women above 25 years
Available in 200+ hospitals across 30 cities and 150+ locations
India, Kenya, Philippines, Sweden, Bulgaria, Turkey, UAE
Regulatory clearance in India, Europe (CE Mark), UAE, Kenya, Philippines; SMILE-100 cleared by US FDA
A concise view of the jobs, capabilities and integrations described in the recorded product sources.
Documented product formats, platforms and official distribution destinations. Availability can vary by region and plan.
A concise history of software releases and material product changes. Events appear only when a dated source supports what changed.
This profile is being checked for dated releases and material product changes. Nothing appears here until the exact date and event can be verified from a recorded source.
Facts, answers, structured details, milestones and primary resource links cite this shared ledger. Each external page appears once; release tags from the same GitHub project are grouped under one release history.
These tools share a workflow, capability or audience with Niramai. They may complement it rather than replace it, and are not presented as integrations or endorsements.
Series A funded by Pi Ventures, Axilor, Ankur Capital, Binny Bansal, Dream Incubator (Japan), BeeNext (Singapore), and 500 Startups (US)
Compliance with ISO 27001, GDPR, HIPAA, and DPDP standards
Hospitals, diagnostic centers (e.g., Apollo Clinics, HCG, Narayana Health), and home screening service on monthly or daily-rental basis
AI-driven breast cancer screening with accurate, non-invasive, radiation-free early detect · Thermalytix is a Novel Artificial Intelligence based medical device for detecting early st · Novel fusion of Artificial Intelligence and Breast Thermal Scans (Thermalytix)
AI-driven breast cancer screening with accurate, non-invasive, radiation-free early detection
Detecting early stage breast cancer
Novel Artificial Intelligence based medical device for detecting early stage breast cancer
Available in 200+ hospitals across 30 cities
Available in 150+ locations across India, Kenya, Philippines, Sweden, Bulgaria, Turkey and UAE
Novel fusion of Artificial Intelligence and Breast Thermal Scans (Thermalytix)
Women of all ages
Regulatory clearance for Thermalytix in India, Europe, UAE and Kenya
US FDA regulatory clearance for SMILE-100 tool (subset of Thermalytix features)
Flat A7-506, Elita Promenade, J P Nagar 7th Phase, Bangalore, KA 560078, India
AI-driven breast cancer screening via Thermalytix platform · Founded July 2016 as NIRAMAI Health Analytix · Headquartered in Bengaluru, Karnataka, India
AI-driven breast cancer screening
Early stage breast cancer detection
Thermalytix
Regulatory clearance in India, Europe, UAE, and Kenya
US FDA clearance for SMILE-100 (subset of Thermalytix features); CE Mark in Europe
150+ locations across India, Kenya, Philippines, Sweden, Bulgaria, Turkey, and UAE; deployed via hospitals and diagnostic centers (e.g., Apollo Clinics, HCG, Narayana Health); monthly or daily-rental basis for corporate/NGO
Women above 25 years (works for women of all ages)
Niramai Health Analytix Pvt Ltd
2016
India
AI-powered breast cancer screening via thermal imaging
Adjunctive diagnostic imaging for thermally significant indications in the breast region
Women of all age groups and breast densities
